cyflow sl.3 cytometer counter Search Results


86
Partec cyflow sl3 flow cytometer
Cyflow Sl3 Flow Cytometer, supplied by Partec, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cyflow sl3 flow cytometer/product/Partec
Average 86 stars, based on 1 article reviews
cyflow sl3 flow cytometer - by Bioz Stars, 2026-05
86/100 stars
  Buy from Supplier

90
Becton Dickinson ethylenediamine tetraacetic acid (edta) vacutainer blood collection tubes
CD4+ T cell counts from patient groups. Patients were grouped according to disease diagnosis plus or minus tuberculosis (TB) chemotherapy into the following groups: controls (Cont), latent TB (Lat‐TB), active TB without chemotherapy (TB+drug–) or with chemotherapy (TB+drug+), TB‐HIV co‐infection (TB+HIV+) and TB‐malaria (TB+MP+) co‐infection. CD4 counts were determined using blood collected in ethylenediamine <t>tetraacetic</t> acid <t>(EDTA)</t> analysed with an automated Cyflow SL.3 cell cytometer. Counts are expressed as cells/μl. Graph shows median and 5–95 percentiles. Statistical significance between groups was determined using a Kruskal–Wallis test with Dunn's multiple comparison correction; *P < 0·05; **P < 0·01; ***P < 0·001; ****P < 0·0001. Significant differences among controls and latent TB and active TB groups are shown in grey. Significant differences among active TB groups are shown in black.
Ethylenediamine Tetraacetic Acid (Edta) Vacutainer Blood Collection Tubes, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ethylenediamine tetraacetic acid (edta) vacutainer blood collection tubes/product/Becton Dickinson
Average 90 stars, based on 1 article reviews
ethylenediamine tetraacetic acid (edta) vacutainer blood collection tubes - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

86
Partec cyflow counting system
CD4+ T cell counts from patient groups. Patients were grouped according to disease diagnosis plus or minus tuberculosis (TB) chemotherapy into the following groups: controls (Cont), latent TB (Lat‐TB), active TB without chemotherapy (TB+drug–) or with chemotherapy (TB+drug+), TB‐HIV co‐infection (TB+HIV+) and TB‐malaria (TB+MP+) co‐infection. CD4 counts were determined using blood collected in ethylenediamine <t>tetraacetic</t> acid <t>(EDTA)</t> analysed with an automated Cyflow SL.3 cell cytometer. Counts are expressed as cells/μl. Graph shows median and 5–95 percentiles. Statistical significance between groups was determined using a Kruskal–Wallis test with Dunn's multiple comparison correction; *P < 0·05; **P < 0·01; ***P < 0·001; ****P < 0·0001. Significant differences among controls and latent TB and active TB groups are shown in grey. Significant differences among active TB groups are shown in black.
Cyflow Counting System, supplied by Partec, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cyflow counting system/product/Partec
Average 86 stars, based on 1 article reviews
cyflow counting system - by Bioz Stars, 2026-05
86/100 stars
  Buy from Supplier

Image Search Results


CD4+ T cell counts from patient groups. Patients were grouped according to disease diagnosis plus or minus tuberculosis (TB) chemotherapy into the following groups: controls (Cont), latent TB (Lat‐TB), active TB without chemotherapy (TB+drug–) or with chemotherapy (TB+drug+), TB‐HIV co‐infection (TB+HIV+) and TB‐malaria (TB+MP+) co‐infection. CD4 counts were determined using blood collected in ethylenediamine tetraacetic acid (EDTA) analysed with an automated Cyflow SL.3 cell cytometer. Counts are expressed as cells/μl. Graph shows median and 5–95 percentiles. Statistical significance between groups was determined using a Kruskal–Wallis test with Dunn's multiple comparison correction; *P < 0·05; **P < 0·01; ***P < 0·001; ****P < 0·0001. Significant differences among controls and latent TB and active TB groups are shown in grey. Significant differences among active TB groups are shown in black.

Journal: Clinical and Experimental Immunology

Article Title: Modulation of the immune response to Mycobacterium tuberculosis during malaria/ M. tuberculosis co‐infection

doi: 10.1111/cei.12861

Figure Lengend Snippet: CD4+ T cell counts from patient groups. Patients were grouped according to disease diagnosis plus or minus tuberculosis (TB) chemotherapy into the following groups: controls (Cont), latent TB (Lat‐TB), active TB without chemotherapy (TB+drug–) or with chemotherapy (TB+drug+), TB‐HIV co‐infection (TB+HIV+) and TB‐malaria (TB+MP+) co‐infection. CD4 counts were determined using blood collected in ethylenediamine tetraacetic acid (EDTA) analysed with an automated Cyflow SL.3 cell cytometer. Counts are expressed as cells/μl. Graph shows median and 5–95 percentiles. Statistical significance between groups was determined using a Kruskal–Wallis test with Dunn's multiple comparison correction; *P < 0·05; **P < 0·01; ***P < 0·001; ****P < 0·0001. Significant differences among controls and latent TB and active TB groups are shown in grey. Significant differences among active TB groups are shown in black.

Article Snippet: Blood samples were collected in ethylenediamine tetraacetic acid (EDTA) vacutainer blood collection tubes (BD Biosciences, San Jose, CA, USA) and CD4 + T cell counts were measured within 5 h of sample collection using a Cyflow SL.3 cytometer for automated CD4 + counts, as per the manufacturer's instructions (Partec, Nuremberg, Germany).

Techniques: Infection, Cytometry